Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1055 Clermont St
Pulmonary 111a, Dvamc
Denver, CO 80220Phone+1 303-393-2869Fax+1 303-393-4639- Is this information wrong?
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1979 - 1982- University of ColoradoResidency, Internal Medicine, 1978 - 1979
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1976 - 1978
Duke University School of MedicineClass of 1976
Certifications & Licensure
CO State Medical License 1980 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1991
Clinical Trials
- 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer Start of enrollment: 1993 Jan 01
- Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers Start of enrollment: 2000 May 01
- Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers Start of enrollment: 2001 May 03
- Join now to see all
Publications & Presentations
PubMed
- 98 citationsLung adenocarcinoma promotion by air pollutants.William Hill, Emilia L Lim, Clare E Weeden, Claudia Lee, Marcellus Augustine, Kezhong Chen, Feng-Che Kuan, Fabio Marongiu, Edward J Evans Jr, David A Moore, Felipe S R...> ;Nature. 2023 Apr 1
- 1 citationsDifferences in VA and Non-VA Pulmonary Nodules: All Evaluations Are not Created Equal.Melissa L New, Erin A Hirsch, William J Feser, Stephen P Malkoski, Kavita Garg, York E Miller, Anna E Baron> ;Clinical Lung Cancer. 2023 Jul 1
- Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.York E Miller, Moumita Ghosh, Daniel T Merrick, Brandi Kubala, Eva Szabo, Lisa Bengtson, Masha Kocherginsky, Irene B Helenowski, Kelly Benante, Tia Schering, Jihye Kim...> ;Frontiers in Oncology. 2023 Jan 1
- Join now to see all
Press Mentions
CU Cancer Center Chemoprevention Trial Hopes to Stop Lung Cancer Before It StartsJune 14th, 2017
Grant Support
- The Biology Of Pulmonary Premalignancy: Application To Risk Assessment And ChemopNational Cancer Institute2008–2011
- Career Development ProgramNational Cancer Institute2008–2011
- Tobacco Related MalignanciesNational Cancer Institute2006–2010
- Biomarkers Of Neoplastic Change In Respiratory EpitheliumNational Cancer Institute2003
- Tobacco Related Malignancies ProgramNational Cancer Institute2001–2002
- Neuropeptide Degradation And Pulmonary CarcinogenesisNational Cancer Institute1996–2002
- Gastrin-Releasing Peptide Receptor Analysis In The LungNational Heart, Lung, And Blood Institute1994–1995
- Bombesin-Like Peptides And Pulmonary CarcinogenesisNational Cancer Institute1992–1995
- Gastrin Releasing Peptide Receptor Analysis In The LungNational Heart, Lung, And Blood Institute1991–1993
- Gene Mapping Of Chromosome 3 And Small Cell CarcinomaNational Cancer Institute1985
Hospital Affiliations
Rocky Mountain Regional Veterans Affairs Medical CenterAurora, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
